FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

CLEARSIGN II Amplifier 40 Channels, CLEARSIGN II Amplifier 80 Channels, CLEARSIGN II Amplifier 120 Channels, CLEARSIGN II Amplifier 160 Channels

K Number: K152693 · Decision Oct 21, 2015
Classifications
1
FEI Numbers
36
Registration Numbers
36
Same Product Code
26
Applicant Total
231
Review Days
30

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
CLEARSIGN II Amplifier 40 Channels, CLEARSIGN II Amplifier 80 Channels, CLEARSIGN II Amplifier 120 Channels, CLEARSIGN II Amplifier 160 Channels
K Number
K152693
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
870.2060
Medical Specialty
Cardiovascular
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Boston Scientific Corporation
Date Received
September 21, 2015
Decision Date
October 21, 2015
Product Code
DRQ
Advisory Committee
Cardiovascular
Review Advisory Committee
CV
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DRQ Amplifier And Signal Conditioner, Transducer Signal

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DRQ), ordered by most recent decision date.

View all

Other Clearances by Boston Scientific Corporation

K Number Device Name
K260428 RIVOS™ EUS Access Device (M00553900)
K260100 MOSES Raydar™
K260771 TruSelect™ 2.6 Microcatheter
K251273 Asurys Fluid Management System
K260479 TheraSphere 360™ Y-90 Management Platform
K260119 SpaceOAR Vue System (SV-2101)
K252529 Moses™ 200 D/F/L Laser Fiber (M0068130100); Moses™ 365 D/F/L Laser Fiber (M0068130110); Moses™ 550 D/F/L Laser Fiber (M0068130120)
K253376 OBSIDIO™ Conformable Embolic (M0013972101010)
K252547 TheraSphere 360™ Y-90 Management Platform
K252921 Radial Jaw 4 Pulmonary Biopsy Forceps
Search all 231 clearances from Boston Scientific Corporation →